White coat hypertension in patients with obstructive sleep apnea-hypopnea syndrome

Chest

Volumn 125, Issue 3, 2004, Pages 817-822

  García Río, Francisco ^a,c   Pino, José M ^a   Alonso, Alberto ^a   Arias, Miguel A ^b   Martínez, Isabel ^a   Alvaro, Dolores ^a   Villamor, José ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL INFANTIL LA PAZ   (Spain)

^c NONE   (Spain)

Author keywords

Ambulatory BP monitoring; Hypertension; Sleep apnea; White coat hypertension

Indexed keywords

ADULT; AGED; ARTERIAL GAS; ARTICLE; BLOOD PRESSURE MONITORING; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; FEMALE; FUNCTION TEST; HUMAN; LUNG VOLUME; MALE; MEASUREMENT; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME; SLEEP PARAMETERS; STATISTICAL SIGNIFICANCE; WHITE COAT HYPERTENSION;

EID: 12144289535     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.817     Document Type: Article

References (38)

1. Carlson JT, Hedner JA, Ejnell H, et al. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994; 150:72-77
2. Bonsignore MR, Marrone O, Insalaco G, et al. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur Respir J 1994; 7:786-805
3. Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 1992; 15:S1-S4
4. Logan AG, Perlikoeski SM, Mente A, et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001; 19:2271-2277
5. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384
6. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165:1217-1239
7. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001; 154: 50-59
8. Pickering TG, Cotas A, Mallion JM, et al. Blood pressure monitoring: Task Force V; white-coat hypertension. Blood Press Monit 1999; 4:333-341
9. Martínez López MA, García Puig J. Hipertensión de bata blanca: ¿tratar o no tratar?. Med Clin (Barc) 2000; 115:221-223
10. Martínez M, Garcia-Puig J, Martin J, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension: a primary care-based study. Am J Hypertens 1999; 12:251-259
11. Staessen J, O'Brien E, Atkins N, et al. Short report ambulatory blood pressure in normotensive compared with hypertensive subjects. J Hypertens 1993; 11:1289-1297
12. Scneider RH, Egan BM, Johnson EH, et al. Anger and anxiety in borderline hypertension. Psychosom Med 1986; 48:242-248
13. Pierdomenico SD, Bucci A, Costantini F, et al. Twenty-four-hour autonomic nervous function in sustained and "white coat" hypertension. Am Heart J 2000; 140:672-677
14. Joint National Committee: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 1993; 153:154-183
15. Pickering T, Kaplan N, Krakoff L. American Society of Hypertension Expert Panel: conclusions and recommendations on the clinical use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996; 9:1-11
16. García-Río F, Racionero MA, Pino JM, et al. Sleep apnea and hypertension: the role of chemoreceptors and the sympathetic system. Chest 2000; 117:1417-1425
17. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Bethesda, MD: National Institutes of Neurological Disease and Blindness, 1968. National Institutes of Health publication No. 204
18. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22:667-689
19. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows: report working party standardization of lung function tests. European Community for Steel and Coal: Official statement of the European Respiratory Society. Eur Respir J 1993; 6(Suppl 16):5-40
20. Armitage P, Berry G. Statistical Methods in Medical Search. Oxford, UK: Blackwell Scientific Publishers, 1987; 296-312
21. Weber M, Neutel J, Smith D, et al. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90:2291-2298
22. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA 1988; 259:225-228
23. Hoegholm A, Kristensen KS, Madsen HN, et al. White coat hypertension diagnosed by 24-h ambulatory monitoring: examination of newly diagnosed hypertensive patients. Am J Hypertens 1992; 5:64-70
24. Flores L, Recasens M, Gomis R, et al. White coat hypertension in type 1 diabetic patients without nephropathy. Am J Hypertens 2000; 13:560-563
25. Verdecchia P, Schillaci G, Boldrini F, et al. Variability between current definitions of "normal" ambulatory blood pressure, implications in the assessment of white coat hypertension. Hypertension 1992; 20:555-562
26. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-381
27. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165:670-676
28. Carels RA, Sherwood A, Blumenthal JA. High anxiety and white coat hypertension. JAMA 1998; 279:197-198
29. Chambers MJ, Kim JY. The role of state-trait anxiety in insomnia and daytime restedness. Behav Med 1993; 19:42-46
30. Hall M, Buysse DJ, Nowell PD, et al. Symptoms of stress and depression as correlates of sleep in primary insomnia. Psychosom Med 2000; 62:227-230
31. Khattar R, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892-1897
32. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: a independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801
33. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249:2792-2798
34. Palatini P, Mornino P, Satonastaso M, et al. Target-organ damage in stage 1 hypertensive subjects with white coat and sustained hypertension: results from the Harvest study. Hypertension 1998; 31:57-63
35. Glen SK, Elliott HL, Curzio JL, et al. White-oat hypertension as a cause of cardiovascular disfunction. Lancet 1996; 348:654-657
36. Ferrara LA, Guida L, Pasanisi F, et al. Isolated office hypertension and end-organ damage. J Hypertens 1997; 15:979-985
37. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, et al. White-coat hypertension and carotid artery atherosclerosis. Arch Intern Med 2000; 160:1507-1512
38. Bidlingmeyer I, Burnier M, Bidlingmeyer M, et al. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14:327-332